Christine Allen

As Associate Vice-President and Vice-Provost, Strategic Initiatives (AVPVP SI), Professor Christine Allen serves as lead for the identification, assessment, prioritization and support of strategic, cross-divisional, excellence-driven, institutional initiatives. She works with the Vice-Presidential, Provostial portfolios and academic divisions to identify these initiatives and to co-ordinate on resources from external agencies and organizations. She also works with the Centre for Research and Innovation Support on training and leadership development. Professor Allen is the GlaxoSmithKline Chair in Pharmaceutics and Drug Delivery at the Leslie Dan Faculty of Pharmacy. She holds a PhD in chemistry. Her research focuses on the design of innovative materials and drug delivery technologies. She is the co-founder and served as President of Nanovista Inc., a company focused on high-precision, image-guided cancer therapy. Professor Allen has also served as the Chief Scientific Officer at Avicanna Inc., a leading biopharmaceuticals company working with cannabinoids. She is the Associate Editor of the Journal of Controlled Release, the President-Elect of the Canadian Society for Pharmaceutical Sciences, and an appointed member of NSERC’s Governing Council and Executive Committee. She has served in several senior academic leadership roles, including Associate Dean, Academic at the Faculty of Pharmacy from 2011 to 2012, Associate Dean, Graduate Education from 2013 to 2015, and most recently Interim Dean from 2018-19.